MedTrace Logo

Messaging Therapy for Depression and Anxiety: A Longitudinal Effectiveness Study

NCT03699488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12980

Last updated 2019-02-06

No results posted yet for this study

Summary

Therapies delivered via technology have been developed to improve accessibility, however, there is limited research regarding messaging therapy in particular, and none that we know of utilizing a longitudinal effectiveness design. The aim of this study was to investigate the overall effectiveness of messaging therapy, identify any contributors to its effectiveness, and to evaluate a dosage effect for this type of treatment.

Conditions

  • Depressive Symptoms
  • Anxiety Disorders

Interventions

BEHAVIORAL

psychotherapy via asynchronous message

Behavioral psychotherapy delivered by asynchronous message using the Talkspace application

Sponsors & Collaborators

  • Columbia University

    collaborator OTHER

  • New York University

    collaborator OTHER

  • Talkspace

    lead INDUSTRY

Principal Investigators

  • Matteo Malgaroli, PhD · New York University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-02-01
Completion
2018-02-01

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03699488 on ClinicalTrials.gov